Updated hourlyHourly refreshThu, Oct 29, 2026
Press Release Database
Recent press releases, indexed by topic.
AI · Healthcare
The U.S. De-identified Health Data Market is projected to reach USD 5.24 Billion and Europe USD 5.65 Billion by 2035, driven by AI, real-world evidence, and privacy-compliant data demand.
The U.S. De-identified Health Data Market is projected to reach USD 5.24 Billion and Europe USD 5.65 Billion by 2035, driven by AI, real-world evidence, and privacy-compliant data demand.
Aug 18 · 15:00·GlobeNewswire
Healthcare
Direct Meds has broadened the patient-facing information available for DirectMax, covering its online clinical-review process, the compounded status of the medication, its licensed-pharmacy fulfillment model, recurring-plan terms, and its prescription safety framework.
Direct Meds has broadened the patient-facing information available for DirectMax, covering its online clinical-review process, the compounded status of the medication, its licensed-pharmacy fulfillment model, recurring-plan terms, and its prescription safety framework.
Aug 18 · 15:00·GlobeNewswire
SaaS · Healthcare
CORTE MADERA, Calif., August 18, 2026--Vero, a predictive health company on a mission to end age-related chronic disease, today announced it is adding cellular resolution to its OrganAge™ platform with an exclusive consumer license to Stanford’s proteomic Cell Clock technology. Developed in the laboratory of Vero co-founder Dr. Tony Wyss-Coray, Cell Clocks measure biological aging across specific cell types, providing a deeper view into the drivers of organ aging and disease risk.
Aug 18 · 15:00·Business Wire
Healthcare · Education
NEW YORK, August 18, 2026--The National Association for Continuing Education (NACE) is pleased to announce that it has been reaccredited as a provider of continuing education by the Accreditation Council for Continuing Medical Education (ACCME), from July 2026 - July 2030. NACE has received a four-year accreditation as a provider of continuing education for the health professions, having achieved compliance with all core criteria for accreditation.
Aug 18 · 15:00·Business Wire
Healthcare · Automotive
Dublin, Aug. 18, 2026 -- The "Health Insurance - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)" has been added to ResearchAndMarkets.com's offering.
Aug 18 · 14:47·GlobeNewswire
Healthcare
SAN FRANCISCO, August 18, 2026--Crescendo Health, a leader in modernizing clinical research data infrastructure, today announced the appointment of David Strutton, PhD, as Chief Scientific Officer (CSO). In this role, Dr. Strutton will lead the company’s scientific strategy, evidence generation frameworks, and customer solutions to advance patient-centric clinical research.
Aug 18 · 14:37·Business Wire
Healthcare · Biotech & pharma
Designation follows recent FDA clearance of the Company's IND application for C-1101, an investigational, potentially disease-modifying non-opioid biologic BURLINGTON, Mass., Aug. 18, 2026 -- Consano Bio, Inc., a clinical-stage biotechnology company advancing novel...
Aug 18 · 12:10·PR Newswire
AI · Healthcare
Sitero today released three Ash agentic workflows simultaneously, covering clinical study setup, continuous data review, and portfolio-level insights, all governed by human review at every step. CORAL GABLES, Fla., Aug. 18, 2026 -- Sitero, a clinical research organization...
Aug 18 · 12:08·PR Newswire
Healthcare
– Jeromy Brink, MD, Mayo Clinic–trained vascular surgeon in Phoenix, is the first surgeon in Arizona to implant Symvess, the first and only FDA-approved bioengineered human blood vessel –
Aug 18 · 12:00·GlobeNewswire
AI · Healthcare
ISELIN, N.J, August 18, 2026--Ephicacy today announced the appointment of Dr. Shekhar Thumake as head of AI, a new role that reflects the company’s growing investment in artificial intelligence across its biometrics operations.
Aug 18 · 12:00·Business Wire
Healthcare · Biotech & pharma
STUART, Fla., August 18, 2026--Stuart Therapeutics, Inc. ("Stuart"), a clinical-stage biopharmaceutical company developing first-in-class collagen-reparative therapeutics to treat eye diseases, today announced the appointment of David Jakeman as chief financial officer. Jakeman will lead the company's finance and accounting operations as Stuart advances its lead candidate, ST-100 for dry eye disease, through completion of its pending Phase 3b clinical trial and into preparations for commercializ
Aug 18 · 11:45·Business Wire
SaaS · Healthcare
ATHLONE, Ireland, August 18, 2026--Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma
Aug 18 · 07:00·Business Wire